Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Handels

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 14, 2025
Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis: An ISPOR Special Interest Group ReportRaymond H Henderson, Chris Sampson, Xavier G L V Pouwels, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 22, 2023
The value of maintaining cognition in patients with mild cognitive impairment: The innovation headroom and potential cost-effectiveness of roflumilastRon Handels, Sabine Grimm, Arjan Blokland, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|April 3, 2021
Self- and proxy-rating of the ICECAP-O for people with dementia: A cross-sectional linguistic validation study in Germany and PortugalAstrid Stephan, Maria J Marques, Anja Bieber, et al.
International Journal of Technology Assessment in Health Care|February 10, 2025
Trial-based economic evaluation of the BrainACT study: acceptance and commitment therapy for anxiety and/or depressive symptoms after acquired brain injurySander Osstyn, Johanne Rauwenhoff, Ron Handels, et al.
Trials|June 22, 2023
The effectiveness and health-economic evaluation of "Partner in Balance," a blended self-management program for early-stage dementia caregivers: study protocol for a cluster-randomized controlled trialSander L Osstyn, Ron Handels, Lizzy M M Boots, et al.
Alzheimer'S Research & Therapy|February 29, 2024
Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer's diseaseLinus Jönsson, Milana Ivkovic, Alireza Atri, et al.
Health and Quality of Life Outcomes|June 18, 2026
Preference-based measures in people with dementia: a systematic review of psychometric propertiesAnouk Lamé, Jan Heijdra Suasnabar, Esmee Adam, et al.
Journal of Alzheimer'S Disease : JAD|June 21, 2021
Effect of a Multidomain Lifestyle Intervention on Estimated Dementia RiskAlina Solomon, Ron Handels, Anders Wimo, et al.
Journal of the American Medical Directors Association|March 2, 2020
Duration of Care Trajectories in Persons With Dementia Differs According to Demographic and Clinical CharacteristicsOlin Janssen, Stephanie J B Vos, Ron Handels, et al.
Pharmacoeconomics|July 29, 2025
The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer's Disease in SwedenXin Xia, Sandar Aye, Oskar Frisell, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 14, 2025
Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis: An ISPOR Special Interest Group ReportRaymond H Henderson, Chris Sampson, Xavier G L V Pouwels, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 22, 2023
The value of maintaining cognition in patients with mild cognitive impairment: The innovation headroom and potential cost-effectiveness of roflumilastRon Handels, Sabine Grimm, Arjan Blokland, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|April 3, 2021
Self- and proxy-rating of the ICECAP-O for people with dementia: A cross-sectional linguistic validation study in Germany and PortugalAstrid Stephan, Maria J Marques, Anja Bieber, et al.
International Journal of Technology Assessment in Health Care|February 10, 2025
Trial-based economic evaluation of the BrainACT study: acceptance and commitment therapy for anxiety and/or depressive symptoms after acquired brain injurySander Osstyn, Johanne Rauwenhoff, Ron Handels, et al.
Trials|June 22, 2023
The effectiveness and health-economic evaluation of "Partner in Balance," a blended self-management program for early-stage dementia caregivers: study protocol for a cluster-randomized controlled trialSander L Osstyn, Ron Handels, Lizzy M M Boots, et al.
Alzheimer'S Research & Therapy|February 29, 2024
Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer's diseaseLinus Jönsson, Milana Ivkovic, Alireza Atri, et al.
Health and Quality of Life Outcomes|June 18, 2026
Preference-based measures in people with dementia: a systematic review of psychometric propertiesAnouk Lamé, Jan Heijdra Suasnabar, Esmee Adam, et al.
Journal of Alzheimer'S Disease : JAD|June 21, 2021
Effect of a Multidomain Lifestyle Intervention on Estimated Dementia RiskAlina Solomon, Ron Handels, Anders Wimo, et al.
Journal of the American Medical Directors Association|March 2, 2020
Duration of Care Trajectories in Persons With Dementia Differs According to Demographic and Clinical CharacteristicsOlin Janssen, Stephanie J B Vos, Ron Handels, et al.
Pharmacoeconomics|July 29, 2025
The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer's Disease in SwedenXin Xia, Sandar Aye, Oskar Frisell, et al.
Pageof 7